|
Re: discovering why some Stage IVs are exceptional responders to herceptin/lapatinib(
StephN - Which vaccine trial did you participate in at UWash??
I am being considered for one at NIH: NCT01730118.
sj
__________________
June 2015 - Stage IV, HER2+++, HR-. Mets to liver, assorted lymph nodes.
June 2015 - Begin THP
October 2015 - End THP, begin H&P. PET-CT shows resolution of mets to liver & lymph nodes.
|